Mind-NRG
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mind-NRG - overview
Location
Geneva, -, Switzerland
Primary Industry
Pharmaceuticals
About
Founded in 2010, based in Switzerland, Mind-NRG is focused on the development of neurological and psychiatric disorders. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood - brain barrier through a receptor-mediated transport to reach its target in the brain.
Current Investors
Index Ventures, LRM
Primary Industry
Pharmaceuticals
Sub Industries
Epidemiology, Pharmaceutical Research & Development
Website
www.mind-nrg.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.